Evolving Treatments of Metastatic CRC: Insights from ASCO 2024 - Episode 1
Overview of Molecular Testing and Barriers in mCRC June 26, 2024
John Marshall, MD , Al B. Benson III, MD, FACP, FACCC, FASCO , Kristen Ciombor, MD, MSCI , Stacey A. Cohen, MD , Marwan Fakih, MD
The panel of CRC experts explores the significance of molecular testing for mCRC patients, emphasizing recommended biomarkers and optimal testing timelines.
Dr Marshall to Dr Cohen: How would you describe the role of molecular testing for patients with mCRC?Which biomarkers are recommended for testing and when are patients tested? Dr Marshall to Panel: Briefly describe commonly used testing strategies of molecular markers for patients with mCRC.Is there a continued role for ctDNA in molecular testing for patients with mCRC? Dr Benson: What are some barriers to molecular testing in practice?